Relatively Consistent Effects of Canagliflozin (CANA) on Outcomes Regardless of Baseline HbA1c in the CANagliflozin CardioVascular Assessment Study (CANVAS) Program

Julio Rosenstock, Ganapathi Bantwal, John P. Wilding, Richard Dumas, Guillermo Gonzalez-Galvez, April Slee, Frank Vercruysse, Kenneth W. Mahaffey, Dick de Zeeuw, Gregory Fulcher, David R. Matthews

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Number of pages3
JournalDiabetes
Volume67
DOIs
Publication statusPublished - 1-Jul-2018
Event78th Scientific Sessions of the American-Diabetes-Association - Orlando
Duration: 22-Jun-201826-Jun-2018

Cite this